Extreme Movers: Gemini 1.5 Pro's picks for 2026-10-12
Gemini 1.5 Pro picked CCI, HUM, MRNA, TMUS, DDOG for a 1-day horizon. Average directional return: -0.62%. Directions called correctly: 60%.
| Experiment | Extreme Movers |
|---|---|
| Model | Gemini 1.5 Pro |
| Prompt version | extreme-movers-v11 |
| Asked | |
| Horizon | 1-day |
| Measured from | 2026-10-09 |
| Measured to | 2026-10-12 |
| Benchmark | SPY |
| Status | Settled |
| Average directional return | -0.62% |
| Directions called correctly | 60% |
| Benchmark return | -0.06% |
The picks
| Rank | Symbol | Direction | Price change | Return in the called direction | Confidence | vs benchmark | Called right |
|---|---|---|---|---|---|---|---|
| 1 | CCI | up | +1.72% | +1.72% | 75% | +1.78% | Yes |
| 2 | HUM | up | +0.38% | +0.38% | 70% | +0.44% | Yes |
| 3 | MRNA | up | -5.00% | -5.00% | 65% | -4.94% | No |
| 4 | TMUS | down | +2.21% | -2.21% | 60% | -2.15% | No |
| 5 | DDOG | down | -2.04% | +2.04% | 60% | +2.10% | Yes |
The model's market view
Equities showed a mixed picture during the source session with major indexes gaining despite high volatility. Telecom towers and managed care names led the gainers on specific company catalysts such as contract upgrades and spectrum agreements, while select tech and healthcare names continued strong rallies. Declines were pronounced in certain wireless telecom operators.
Why each pick
CCI
Crown Castle shares soared 15.6% following positive sentiment around a reported spectrum agreement involving Grain and SpaceX, as well as a technical breakout that saw active institutional buying. The stock broke heavy resistance. We expect a continuation of the upward move over the next session as momentum funds chase the newly formed higher trading range.
HUM
Humana rallied 14.82% after the Centers for Medicare and Medicaid Services released 2027 Star Ratings, showing Humana's largest Medicare Advantage contract increased from 3.5 to 4 stars. This critical fundamental catalyst qualifies the company for lucrative quality bonus payments and triggered a massive short squeeze. We anticipate a continuation of the uptrend.
MRNA
Moderna shares added 14.2% during the session, extending a powerful one-month surge of roughly 65%. While technically overbought, momentum remains robust and short sellers are being forced to cover. We predict a brief continuation of the rally in the next trading session before any significant pullback materializes.
TMUS
T-Mobile US plunged 13.27%, tracking for its lowest close since late 2023. This severe negative momentum suggests institutional distribution and broader sector rotation away from the name. We anticipate the downward pressure will continue into the next session as analysts revise price targets lower.
DDOG
Datadog cleared a major technical resistance level to reach a new 52-week high, rising 7.1%. Despite some insider selling over the past 90 days, the breakout attracts fresh momentum buyers. However, given the sharp intraday move and high valuation multiples, we hypothesize a minor mean-reversion reversal for the upcoming target session as traders lock in quick gains.
Other models on the same run
| Model | Picks | Average directional return | Directions called correctly |
|---|---|---|---|
| Grok 4.5 | CCI, MRNA, HUM, TMUS, T | -1.30% | 40% |
| Muse Spark 1.1 | LITE, CIEN, HUM, T, FSLY | -1.63% | 60% |
| GPT-6 | TMUS, HUM, CCI, AMT, ASTS | +0.33% | 60% |
| Perplexity | HUM, TMUS, T, CCI, ASTS | +0.26% | 60% |
| DeepSeek | FSLY, NVAX, TMUS, HUM, ALHC | -3.63% | 40% |
| Claude Sonnet 5.5 | HUM, MRNA, TMUS, CCI, FSLY | +3.13% | 80% |
Written up on ForecastNest Insights: Extreme Movers: Gemini 1.5 Pro's picks for 2026-10-12.
ForecastNest provides AI-generated market analysis and quantitative research for informational and educational purposes only. Nothing here constitutes financial, investment, legal, or tax advice.